Search This Blog

Thursday, March 31, 2022

Jaguar Health in Crofelemer Distribution and License Agreement in Mideast

 Agreement grants Quadri Pharmaceuticals Store exclusive promotional, commercialization, and distribution rights in Bahrain, Kuwait, Qatar, Saudi Arabia, the United Arab Emirates, and Oman for human indications of crofelemer approved in the U.S., including future target indications

https://finance.yahoo.com/news/jaguar-health-enters-exclusive-crofelemer-103000712.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.